Furthermore, several growth factor signaling pathways, such as those related to epidermal growth factor and platelet-derived growth factor, are also enriched (Fig. 2B), indicating that abnormal signaling and cellular growth responses might contribute to cardiac hypertrophy and fibrosis, both hallmark features of HCM. The gene discussed is EGF; the disease is cardiac hypertrophy.